Niche Pharmaceutical Valuation Software Business for Sale - Low Down Payment, Royalty-Based Financing

This listing presents a unique opportunity to acquire a niche software business specializing in pharmaceutical valuation. The company's flagship product offers advanced tools for project evaluation and portfolio analysis, providing flexibility and user-friendliness superior to traditional methods like Excel. It enables real-time decision-making, financial projections, and portfolio optimization using sophisticated modeling techniques. While revenue has historically come from consulting services and licensing fees (up to $50,000 annually), the business is currently underutilized in direct software sales, indicating significant growth potential. The sale includes the source code, with the current owner available for paid programming and development support. The business requires a low upfront investment of $25,000, with the balance paid via a 20% royalty on future sales, making it a low-risk acquisition. The seller will retain usage rights for consulting, allowing the buyer full control over software sales expansion. Experienced staff are willing to continue with the new owner, ensuring operational continuity. The business was established in 2020 and is located in Las Vegas, NV.